Breaking AI & Tech News Analyzed

The CEO Disconnect: Analyzing the 'AI Psychosis' Phenomenon Box founder Aaron Levie has ignited a necessary conversation within the tech industry with his recent assertion that tech CEOs are uniquely prone to 'AI psychosis.' Levie’s comment suggests that while executives are aggressively pushing AI integration, they remain 'distant from the last mile of work,' leading to a disconnect where tools are mandated without genuine understanding of their utility or impact on the workforce. This phenomenon is part of a broader, polarizing trend where AI is simultaneously embraced and rejected, creating a complex landscape for both consumers and businesses. Google's Search Overhaul and the Rise of Anti-AI Sentiment Google’s recent announcements at its annual developer conference have become the focal point of this backlash. The tech giant is aggressively integrating AI into its search experience, moving away from the traditional '10 blue links' model toward a more conversational, AI-driven interface. However, this shift has caused confusion and alienated long-time users who value the simplicity and predictability of the classic search engine. The company’s vague messaging regarding how these changes will coexist with existing features has further eroded trust among its core user base. The 30% Surge in DuckDuckGo and User Backlash The consumer reaction to Google’s AI pivot is tangible and measurable. Following the announcement of more AI features, DuckDuckGo reported a significant 30% increase in installs. This surge indicates a substantial market shift driven by user distrust of AI integration. Additionally, the polarization is evident among younger demographics, with graduating college students booing mentions of AI, suggesting a generational divide on the technology's role in education and information retrieval. The Disconnect Between Executive Vision and Workforce Reality The core of Levie's argument lies in the 'last mile' problem. Unlike previous technological revolutions where adoption was often bottom-up—employees adopting tools they found useful—AI integration appears to be driven top-down by executives and venture capitalists chasing efficiency dreams. This top-down mandate ignores the reality of how these tools function on the ground, leading to a workforce that is skeptical of AI-driven productivity gains, especially when coupled with the backdrop of tech industry layoffs. The Future of AI Adoption: From Top-Down Mandates to Bottom-Up Integration The current 'anti-AI moment' may serve as a pivotal opportunity for startups and alternative business models. As established players like Google struggle to balance innovation with brand identity, there is a growing lane for services that prioritize user privacy and traditional search experiences. For the industry to move forward, CEOs must bridge the gap between their strategic vision and the actual user experience, moving from abstract efficiency slides to a genuine understanding of how AI tools function in daily workflows.

The Lead: Arsenal's Mixed Season of Triumph and HeartbreakArsenal's 2025-2026 season encapsulated both remarkable achievement and painful disappointment. While the club secured its first Premier League title since 2004 under Mikel Arteta's leadership, they also endured the agony of losing two finals, most recently the Champions League final against PSG on penalties. This duality defined a season that stretched players to their physical and mental limits.The Season Marathon: Physical and Mental Toll on PlayersDeclan Rice emphasized the extraordinary demands of the season, noting that Arsenal's journey began in July with a pre-season match in Singapore and concluded with their 63rd game across all competitions. The midfielder highlighted the particularly grueling stretch from October onward, when the team faced three matches per week. Rice himself played in 55 of Arsenal's matches while battling through a persistent injury that left him operating at '70%' fitness for 'quite a while,' according to Thomas Tuchel.The Final Performance: Tactical Execution and Individual FlawsIn the Champions League final, Arsenal demonstrated their tactical discipline under Arteta's guidance. After Kai Havertz's early goal, the team effectively neutralized PSG's formidable attack until Cristhian Mosquera conceded a penalty that led to Ousmane Dembélé's equalizer. However, the match exposed several persistent issues: Arsenal's pass completion rate was a concerning 69% compared to PSG's 91%, and they made only 196 successful passes to PSG's 806. Individual attacking statistics were equally troubling, with Bukayo Saka completing just four passes and Martin Ødegaard touching the ball only 12 times.The Penalty Shootout: Misses and Mental FortitudeThe final's conclusion on penalties highlighted both Arsenal's resilience and their remaining vulnerabilities. Gabriel Magalhães missed the decisive fifth penalty, continuing a pattern that saw him miss in a pre-season shootout against Villarreal. Eberechi Eze's penalty technique, which had previously failed him in Crystal Palace's Community Shield victory, resurfaced with identical results against Arsenal. Despite these setbacks, Declan Rice's successful conversion in round three symbolized the team's character and determination throughout the match.Arteta's Evolution: From 'Mikelito' to Respected ManagerThe final showcased Mikel Arteta's growth as a manager, particularly in how his players executed the gameplan against PSG. Luis Enrique's affectionate yet potentially patronizing use of Arteta's old nickname 'Mikelito'—a reference to his time as a young hopeful at Barcelona—underscored the respect Arteta has earned. The Arsenal manager's ability to nullify Europe's most feared attack demonstrated his tactical acumen, even as the team's lack of precision in final passes revealed areas for continued development.The Road Ahead: Building on ProgressArsenal's season, while ending in Champions League final heartbreak, represents significant progress under Arteta. The combination of Premier League triumph and European final appearance establishes a foundation for future success. The physical and mental resilience demonstrated throughout the season, particularly in the face of such a demanding fixture schedule, suggests that the team is building the necessary characteristics to compete at the highest level consistently. As Rice noted, the experience gained from this grueling campaign will fuel their ambitions in seasons to come.

The LeadA daily pill has shown remarkable results in doubling survival time for patients with pancreatic cancer, the world's deadliest form of the disease. According to clinical trial results presented at the American Society of Clinical Oncology's annual meeting, this breakthrough treatment represents a potential revolution in how we approach a cancer that has seen limited progress for decades.The Breakthrough Drug: DaraxonrasibThe drug in question, daraxonrasib, works by targeting a protein called Kras that fuels nearly all pancreatic cancers. This mechanism represents a significant advancement in treatment strategy, as Kras has been notoriously difficult to target effectively. The drug functions as a Ras(On) multi-selective inhibitor, capable of turning off the Kras protein to stop cancer growth regardless of which variant is present.Impressive Trial ResultsIn the clinical trial involving 500 patients with advanced pancreatic cancer, the results were striking. Those who took daraxonrasib lived an average of 13.2 months, compared to just 6.6 to 6.7 months for patients who received chemotherapy. This represents a near doubling of survival time, with the added benefit of fewer side effects compared to traditional chemotherapy treatments.Industry Impact and Expert ReactionsThe findings have been hailed as a "gamechanger" and "grand slam" by experts in the field. Dr. Rachna Shroff, chief of oncology at the University of Arizona Cancer Center, described the results as "landscape-changing" and "unprecedented survival." When she first read the trial results, conducted by researchers at the Dana-Farber Cancer Institute in Boston, she wept, noting the profound impact this could have on patients after 16 years of treating pancreatic cancer.Dr. Julie Gralow, Asco's chief medical officer, echoed these sentiments, calling the study a "home run" and suggesting it was actually a "grand slam" in terms of its significance.The Ras RevolutionOver 90% of patients with the most common form of pancreatic cancer, pancreatic ductal adenocarcinoma (mPDAC), have a mutation in the Kras gene. This discovery has long been considered the "holy grail" in cancer research, particularly for pancreatic cancer where the mutation is nearly ubiquitous and an early driver of cancer growth.Paula Hanford, chief executive of UK-based Pancreatic Cancer Action, called this one of the most significant developments in treatment she had ever seen. Similarly, Anna Jewell, director of services, research and innovation at Pancreatic Cancer UK, described the results as "exciting," noting that the drug gives patients "months more precious time with their loved ones."Future Outlook and ApplicationsThe success of daraxonrasib opens doors for similar treatments targeting Ras genes in other cancers. Experts at the conference noted that because Ras genes fuel various types of cancer, there is hope for breakthroughs in treating lung and colon cancers as well, with similar drugs already in development for these conditions.However, challenges remain in ensuring these promising treatments become widely available to patients. As Jewell pointed out, tragically half of all people with pancreatic cancer die within just three months of diagnosis, making the rapid implementation of such treatments crucial.

The Architecture of an African GiantIn less than two decades, Morocco has redefined African football, evolving from a team frequently eliminated in group stages to a global powerhouse ranked in the top 10 of the FIFA men’s rankings. This meteoric rise is not accidental but the result of a long-term national project initiated by King Mohammed VI in 2008.The success is built on three distinct pillars: good governance, financial investment, and competent human resources. The first step involved creating a national department for financial control to professionalise the federation's structure. This was followed by a massive infrastructure overhaul, including the construction of thousands of 'proximity fields' for mass participation and the Mohammed VI Complex in Maamoura, a technical center often compared to France's elite Clairefontaine academy.A Trophy Cabinet OverflowingThe impact of this strategy is evident in the sheer volume of recent accolades. The Atlas Lions have dominated across every age group, securing titles that span senior, youth, and women's football:2025 AFCON Champions (after Senegal were stripped of the title)2025 WAFCON Finalists2025 FIFA Arab Cup Champions2025 African Nations Championship (CHAN) Champions2025 U-20 FIFA World Cup Champions2025 U-17 AFCON Champions2024 Olympic Men’s Bronze Medallist2024 Futsal AFCON ChampionsThe Diaspora Strategy and Infrastructure BoomA critical factor in Morocco's ascent is the reform of national eligibility rules, which opened the door to players from the European diaspora. This strategy has attracted stars like Hakim Ziyech, Nordin Amrabat, and Brahim Diaz.The latest addition to this lineage is Ayyoub Bouaddi, an 18-year-old Lille midfielder. Despite interest from Zinedine Zidane and the French national team, Bouaddi chose to represent Morocco, highlighting the magnetic pull of the national project. The Mohammed VI Complex has already produced top talent, including Nayef Aguerd, Azzedine Ounahi, and Youssef En-Nesyri.Navigating the 2026 World Cup and the 2030 DreamWith high expectations for the 2026 World Cup in the USA, Canada, and Mexico, Morocco faces a transitional period following the resignation of coach Walid Regragui after the controversial 2025 AFCON final. The federation has appointed Mohamed Ouahbi, who led the youth team to the U-20 World Cup title.While Ouahbi’s more adventurous style differs from Regragui’s pragmatic resilience, the foundation is solid. The world views Morocco as a credible contender, but the team understands that the 2026 tournament is merely a milestone. With Morocco set to co-host the 2030 World Cup alongside Spain and Portugal, the current success is viewed as the acceleration of a broader national development agenda.

The Lead: Liverpool at a CrossroadsAs Liverpool prepares for life after Arne Slot, the club faces significant challenges that will define their immediate future. The Dutchman's tenure ended without the dominance expected, leaving a squad in need of strategic overhaul both on and off the pitch. The new manager inherits a team that must rediscover its identity while addressing key personnel departures and tactical shortcomings.Style Evolution: From Heavy Metal to Soft RockPerhaps Mohamed Salah's style of communication wasn't the slickest, but he was correct that Liverpool need to redefine the style of football they play. Everything on the pitch last season under Arne Slot felt very placid as Liverpool failed to dominate opponents and were often found overrun. The new head coach will want to demonstrate his plans and implement an attacking style to best use what is available to him. Anfield does not want to witness back-foot football, fans want to see a swagger to those in red. Supporters and Slot suffered from a disconnect in the final months. The Dutchman was hindered by not possessing the vivacious personality of Jürgen Klopp nor the results in the end, and the aforementioned tedious style. The successor will want to put fans at the forefront and build a strong bond between stands and dugout, built on a platform of attractive play.Investment Analysis: Underperforming Key SigningsAfter spending heavily last summer trying to build a squad capable of dominating the Premier League for years to come, it was difficult to pick out someone who thrived. Hugo Ekitiké was the best of the new arrivals but record signings Florian Wirtz and Alexander Isak barely made the season's footnotes. Isak could at least attribute his struggles to fitness and injury problems, including a leg fracture, but the German's first taste of English football was a sour one. He never looked comfortable as a No 10, physically finding it tough going as speed on the ball and strength in battle were lacking. Getting the best out of a clearly talented player must be a priority, because Wirtz has the capabilities to open defences and help Liverpool control games but needs a confidence boost and an arm around the shoulder.Structural Impact: Midfield Deficiencies and Leadership VacuumWirtz is part of a wider midfield issue that lacks physicality and an obvious No 6. Ryan Gravenberch was elected as the man for the role by Slot, which worked well when the possession stats were in Liverpool's favour but finding someone who can break things up effectively is advisable. Every other team have someone who can break up play but Liverpool lack someone in that role. Not since Georginio Wijnaldum or Fabinho have the club possessed someone capable of overwhelming opponents with their physical attributes and in an evolving sport, this oversight must end. Dominik Szoboszlai being moved around the pitch was unhelpful because he can be one of the best central midfielders in the world but needs a defined position to make his own.The players departing Anfield are weighed down with individual and team trinkets, thanks to the success they have enjoyed with Liverpool. Arguably, the influence of Salah and Andy Robertson on the pitch waned in their final season with the club but their experience and winning mentality will be a huge loss to the dressing room and training ground. Ibrahima Konaté is another exiting, providing a recruitment headache the club were not fully anticipating. It does beg the question if it is the right time to allow Alisson Becker, who has suffered from injury problems in recent times, to be sold and allow a new generation to start afresh, with Virgil van Dijk leading the transition. There are plenty of potential internal candidates who can take on greater responsibility but it may require a change in transfer strategy to acquire players in their late-20s with Champions League experience to help give the right balance.Defensive Rebuild: Addressing Key DeparturesKonaté's contract expiration will be softened by Jérémy Jacquet's impending arrival but further investment is required. Van Dijk's longevity is unknown so finding a partnership for the long term will be critical; a more rugged centre-back like Nottingham Forest's Murillo could be an ideal choice to offer balance and greater aggression. Competition for Milos Kerkez will be important, but if Andoni Iraola does take the job the reunion could get the best out of the Hungarian and get him to flourish after a mixed first year on Merseyside. On the opposite side, continuity would help everyone because Slot was forced to trying numerous people in the role, many out of position. Ideally, Conor Bradley or Jeremie Frimpong can make it their own, having struggled to replace Trent Alexander-Arnold, although both have suffered with injury problems. If they can stay fit, they both possess the quality to be a solution, especially if clever coaching can embrace their attacking prowess and incorporate more defensive discipline.Future Outlook: Rebuilding the AttackSlot insisted that new wingers would change the dynamic next season but he will not be the one to benefit. Salah is off, Federico Chiesa cannot carry on as a bit-part, so will almost certainly leave too, freeing up some space on the flanks. Rio Ngumoha offered brief teenage glimpses of excitement as someone with the pace and trickery to get past full-backs. Frimpong, brought in as a right-back, was more often found on the wing because he possessed the speed Slot desired in those areas, while also offering a further indication that the transfer dealings left a lot to be desired. They did not replace the maverick tendencies of Luis Díaz and Cody Gakpo has never looked a natural winger. Targeting new wide men will be imperative. RB Leipzig's Yan Diomande, Brighton's Yankuba Minteh or Athletic Club's Neco Williams would be ideal candidates to bring thrust to a side lacking dynamism and get supporters off their seats.

Martin Parr—renowned for documenting the idiosyncratic corners of British life—was given a farewell as unconventional as his work. On 31 May 2026, the chapel at Woodlands Memorial Garden near Bristol hosted a colourful country‑fete celebration, complete with music from The Girl from Ipanema, bunting, and a bus that famously got stuck in the mud. The Fete‑Style Send‑off That Defied Funeral Norms The ceremony blended solemnity with the photographer’s trademark humour. Guests were served cling‑film‑wrapped sandwiches, cupcakes with tiny Union Jack flags, and a tombola of unwanted Christmas gifts—an homage to the annual auction the Parr family used to run. The event was organised with help from the Martin Parr Foundation and featured a collaborative food installation by Ellen Parr (the photographer’s daughter) and set‑designer Alice Hodge. Key Players and Personal Touches Grayson Perry – celebrated artist and longtime friend, described the service as “tasteful, pared‑back and very touching.” Sophie Green – photographer who documented the funeral, linking the occasion to her “Death Rituals” project. Helô Pinheiro – the original “Girl from Ipanema,” whose music featured in the playlist. Family – Susie Parr, Martin’s wife of 40 years, confirmed he would have wanted the ceremony photographed. Why Parr’s Funeral Resonates in the Photography Community Parr spent half a century turning the mundane into visual satire; his own send‑off mirrored that ethos. By inviting a photographer to capture the event, the family highlighted a long‑standing taboo—funeral photography—while honoring Parr’s fascination with death rituals, evident in his 1993 Indonesian funeral series and the 2013 Photographers’ Gallery exhibition. What This Means for Future Death‑Ritual Documentation Sophie Green’s involvement underscores a growing interest in recording funerary moments as cultural artifacts. She notes that, on average, she photographs five funerals a year, a figure that may rise as artists and families seek more personalized memorials. The blend of celebration and documentation at Parr’s funeral could inspire a new genre where mourning and festivity coexist, reshaping how societies view death. Looking Ahead: From Taboo to Tribute As the conversation around death becomes more open—accelerated by pandemic‑era restrictions—events like Parr’s funeral suggest a shift toward inclusive, creative rituals. Institutions such as the Martin Parr Foundation may increasingly support projects that capture these moments, offering both solace to grieving families and valuable visual records for future generations.

The Lead: Unprecedented Cancer Treatment SuccessDoctors have hailed "unprecedented" trial results that show a triple-action cancer jab can eradicate entire tumours in patients. In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments.The Breakthrough: Amivantamab's Triple-Action ApproachThe jab, called amivantamab, shrank the tumours of more than a third of patients, with dramatic changes seen within weeks. In 15 of them, doctors found the drug had melted away their tumours altogether.The smart jab targets cancer in three ways. It blocks both EGFR (epidermal growth factor receptor), a protein that helps tumours grow, and MET, a pathway that cancer cells often use to escape treatment. It also helps activate the immune system to attack the tumour.The Clinical Trial Data: Impressive Response RatesIn the trial, 102 patients with head and neck cancer, the world's sixth most common cancer, were given the jab. Tumours shrank or disappeared completely in 43 patients, including 28 whose tumours shrank significantly and 15 who saw them eradicated entirely.Patients receiving amivantamab lived for a median of 12.5 months overall after starting treatment, despite having a form of cancer with very poor outcomes, once standard treatments stop working.The Impact Analysis: New Hope for Treatment-Resistant CancersKevin Harrington, professor in biological cancer therapies at the Institute of Cancer Research, London (ICR), said: "These are unprecedentedly strong responses in patients whose disease has become resistant to both chemotherapy and immunotherapy. This is a group of patients for whom treatment options are extremely limited, so seeing this level of benefit is very striking."Researchers also highlighted that the trial focused on people with head and neck cancers that did not include those with human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. That is particularly significant, they said, since head and neck cancers not caused by HPV are usually harder to treat, making progress in this group hugely important.The Patient Experience: Transforming Quality of LifeOne of the first patients to benefit was Carl Walsh, 56, who was diagnosed with tongue cancer in May 2024 and joined the OrigAMI-4 trial at the Royal Marsden in July 2025. "I was initially treated with both chemotherapy and immunotherapy, which unfortunately were not successful," he said. "At that point, I was recommended for the OrigAMI-4 trial. I'm now on my 17th cycle of treatment and I'm very pleased with the progress so far."Unlike many cancer treatments, amivantamab is given as a tiny jab under the skin rather than via an intravenous drip, making treatment quicker and more convenient for patients and much easier to deliver in outpatient clinics.The Future Outlook: Expanding Treatment ApplicationsThe results will be presented on Sunday in Chicago at the world's largest cancer conference, the annual meeting of the American Society of Clinical Oncology (Asco).Amivantamab, developed by Johnson & Johnson, is now being evaluated in about 60 clinical trials, primarily for lung cancer, but also for colorectal, brain and gastric cancers.Prof Kristian Helin, the chief executive of the ICR, said: "This study demonstrates how the development of new treatments through rigorous cancer research may lead to meaningful advances, even for patients with very limited treatment options. Achieving this level of tumour response and encouraging survival outcomes in such a challenging-to-treat group represents a significant step forward."

The Rise of Nigeria's Digital Herbal Marketplace In Abuja, Nigeria, Oke Bola thought a fertility supplement she found online might help her conceive. Instead, within days of taking it, she struggled to breathe. Her experience reflects a growing online trade in unverified herbal remedies promoted across social media platforms. Bola, who is in her early 40s and has never had children, bought the supplement earlier this year and increased the recommended dosage, hoping for quicker results after hearing about it from friends and family. "I recognised the symptoms of asthma; the wheezing sound at night was familiar," she told Al Jazeera. "When I checked online, I realised it could be from the herbal medication." Her experience is not isolated. Across Nigeria, doctors and pharmacists report a surge in social media-driven self-medication, particularly involving unverified herbal products. This trend is worsening health outcomes, delaying treatment, and adding pressure to an already strained healthcare system serving about 230 million people. Nigeria's young, hyperconnected population increasingly uses digital platforms for health information and advice. But that access has also created what Dr Isaac Kolawole and Dr Fidelis describe as an "algorithmic apothecary" – an unregulated online marketplace where influencers and anonymous sellers promote remedies directly to consumers with little or no scientific backing. Health Impacts of Unverified Herbal Remedies Within this ecosystem, herbal remedies, long part of Nigeria's medical and cultural landscape, are increasingly repackaged as miracle cures, sometimes with dangerous consequences. Doctors report more patients arriving at hospitals only when their conditions have significantly worsened, often after prolonged use of unverified treatments. A consultant nephrologist at the University College Hospital in Ibadan, Dr Yemi Raji, said herbal medicine continues to play a role in kidney disease cases in Nigeria. "When you take herbal medication, you are taking both the good and the bad," he said. "Patients often arrive late, when treatment is more difficult and expensive." Dialysis alone can cost between 50,000 and 100,000 naira ($36-72) per session, several times a week. Studies link herbal use to kidney and liver disease cases across Africa, including findings that about 46 percent of liver disease admissions in one Nigerian hospital involved herbs or roots. A 2022 study found that 76.65 percent of participants had used herbal medicine, with more than a third combining herbal and conventional treatments while 82.44 percent did not inform their doctors. The Algorithmic Amplification Effect On a smartphone screen, relief is just a click away: fertility tonics, eye drops promising restored vision, syrups claiming to "flush out" disease. The advertisements are polished, persuasive and constant, woven into TikTok, Facebook, Instagram and X feeds. "The platforms themselves amplify this effect," said Dr Egemba Chinonso Fidelis, a public health advocate known online as Aproko Doctor. "Their algorithms reward engaging content and push it to wider audiences." Even users who try to avoid such content often encounter it repeatedly, shaped by emotional storytelling, music and urgency-driven messaging. A 2025 Nigeria-based study on Jinja Herbal Mixture found it appeared safe for short-term use within tested dosage ranges, but researchers recorded biochemical changes at higher doses, including altered creatinine and sodium levels in test subjects, signs of possible kidney and liver stress. The study called for further research into long-term effects and interactions with conventional medicines. Regulatory Challenges in the Digital Age The National Agency for Food and Drug Administration and Control (NAFDAC) says it is working to track unregistered manufacturers, but enforcement remains difficult, especially online. "With the sheer volume of products online, enforcement has limited reach," said Isaac Kolawole, the southwest zonal director of NAFDAC. Many sellers use fake or incomplete addresses, making them difficult to trace. NAFDAC requires strict registration, testing and approval before herbal products can be sold or advertised, but regulation has not kept pace with online commerce. Fidelis argued that stronger regulation alone is not enough. "If there are no consequences for lying about healthcare online, people will keep doing it," he said. He noted that scammers have even used AI-generated versions of his image to promote fake products. "Real medicine does not promise to cure everything, and it does not rely on countdowns," he added. "Scammers do." Path Forward for Safer Digital Health As Nigeria's digital economy expands, the intersection of technology and healthcare will only grow more complex. Fidelis stressed that access to affordable healthcare must improve, public trust must be rebuilt, and digital platforms must take responsibility for the health content they amplify. Pharmacist Akinade Akinlolu noted that while conditions like diabetes and hypertension can be managed, online claims often suggest cures. "Economic pressure is also pushing people towards cheaper or 'miracle' alternatives," he added. "Without stronger safeguards," Fidelis warned, "the algorithmic apothecary will continue to grow and put more people at risk." The challenge for Nigeria's healthcare system is to harness the power of digital platforms while ensuring they promote evidence-based care rather than potentially harmful alternatives.

The Government's Response to the Youth Employment CrisisA former chief executive of Marks & Spencer has been appointed as a government jobs adviser in its latest attempt to tackle the growing youth unemployment crisis. Marc Bolland, who oversaw the retail chain from 2010 to 2016, will lead a summit of business leaders, amid warnings that the country risks a "lost generation" without urgent intervention.The Scale of the Youth Unemployment ChallengeAbout 1 million people aged 16 to 24 – about one in eight – are not in education, employment or training. An interim report published by the former health secretary Alan Milburn warned that this cohort – known as Neets – could increase to 1.25 million by the 2030s without radical action. The proportion of Neets in the UK is significantly higher than in many other developed countries. In the Netherlands, about 5% of 16 to 24-year-olds are not in education or work, while it is about 12.5% in Britain.Bolland's Role and StrategyIn light of Milburn's findings, Bolland has been appointed as lead non-executive director at the Department for Work and Pensions (DWP), Downing Street said. Bolland, who also led supermarket Morrisons, is understood to have been chosen for the role thanks to his existing involvement with the DWP via his charity Movement to Work. The government said a collaboration with Movement to Work had already helped more than 200,000 unemployed young people find jobs.Economic Impact of Youth UnemploymentThe economic cost of the crisis is estimated to be about £125bn. Milburn's report found that six in 10 young people have never had a job, compared with four in 10 in 2005. He said that an increasing number of young people were being ruled as unfit to work due to health conditions including anxiety, depression and neurodevelopmental conditions. However, it is estimated that for every £25 the government spends on benefits for young people, it devotes just £1 to helping them find work.Focus on Vulnerable GroupsA central part of Bolland's role will be to work with charities supporting disabled young people to ensure they have access to training and employment opportunities. Almost half of those who claim a health or disability benefit before the age of 24 are still unemployed or not in education a decade later.Future Outlook and CollaborationThe government said Bolland would work with "leading chief executives across sectors" to "create clear routes into work and tackle the longstanding challenge of youth unemployment." It added that he would also advise the work and pensions secretary, Pat McFadden, on how the government should respond to Milburn's findings. McFadden said that Bolland's appointment sent a "clear signal" that the government was "serious about tackling that challenge" of youth unemployment. Bolland said he was "honoured and passionate" about working with the government, adding: "I know that working hand in hand with business to support young people gives them the best possible chance of success."